Your browser is currently set to block JavaScript.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

After enabling javascript, please refresh the page to go back to site with full functionality

Would you turn off/on JavaScript?

It's a widely used language that makes the web what it is today, allowing for websites to be more responsive, dynamic, and interactive. Disabling JavaScript takes websites back to a time when they were simple documents without any other features.

What are the advantages of using JavaScript?

Speed. Since JavaScript is an 'interpreted' language, it reduces the time required by other programming languages like Java for compilation. JavaScript is also a client-side script, speeding up the execution of the program as it saves the time required to connect to the server.

banner ad
Experts Logo


The Goldhaber Warnings Report: The U.S. Supreme Court Ruling (Levine vs. Wyeth) Has MAJOR Implications For Potential WARNING Claims Against Pharmaceuticals, Other Health Care Companies And Many Leading Manufacturers

By: Gerald M. Goldhaber, Ph.D.
President & CEO GRA LLC

Office: (212)379-6661
Cell: (917)279-2303
Email Dr. Gerald Goldhaber

View Profile on

View PDF version of the Goldhaber Warnings Report - Vol. 1

The U.S. Supreme Court ruling (March 5, Levine vs. Wyeth) will have major implications for the pharmaceutical industry forcing them literally to review all of their warnings and safety instructions for content, clarity and conspicuousness. The industry, unlike manufacturers of Class III medical devices (e.g., stents, defibrillators, etc.) which were preempted from warnings claims (Riegel vs. Medtronics) in a 2008 8-1 Supreme Court ruling, will now be forced to proactively review all of its drug warnings and safety instructions to make sure they are up to "best practices" for the warnings and safety communications industry. Even the medical devices industry may soon have to take a similar step because Congress is very likely to pass a law (spearheaded by Ted Kennedy)that will mandate certain warnings for Class 3 devices and allow products liability claims against companies violating these warnings, thus negating the Supreme Court original ruling and making it likely that the court will ultimately have to resolve the inconsistencies between the two rulings. The implications go even further for ANY company which has attempted to use a preemption defense in a products liability lawsuit. The manufacturer of ANY PRODUCT will have to ensure that their warnings and safety communications meet the "best practices" of the warnings industry. The answer is very simple for any defendant confronting this issue: Conduct an immediate review/evaluation/testing program for any warnings and safety communications at potential risk for claims and costly litigation.


  1. What hazard(s), risks and dangers that are known or likely to be known to us (the manufacturer) exist or are likely to exist with the use of our product(s)?
  2. Who is the likely user of our products that may be hazardous, and are these hazards, risks and dangers open and obvious to the average consumer at the time of use?
  3. If the hazards exist and are unknown or hidden to the user, how can we best communicate with or warn the user about these hazards, their consequences and how to eliminate or reduce the risk of exposure to these consequences?
  4. If there are standards or regulations that would govern the content and/or method to warn about these hazards, what are they and how can we conform with them?

I will be providing more details about the implications of this decision and a program for evaluating warnings in the next issue of THE GOLDHABER WARNINGS REPORT. At this time, however, I would be happy to discuss (in a free consultation) a detailed warnings review program with anyone reading this newsletter or any of their relevant colleagues/contacts. Please contact me directly if you would like to set this up or if you or someone you know should get my FREE monthly newsletter exclusively devoted to warnings and safety communications issues.

Dr. Gerald M. Goldhaber, the president of Goldhaber Research Associates, LLC, is a nationally recognized expert in the fields of political polling and warning label research. His clients include Fortune 500 companies, as well as educational and governmental organizations. He has conducted hundreds of surveys, including political polls for candidates running for U.S Congress, Senate, and President. Dr. Goldhaber also served as a consultant to President Reagan's Private Sector Survey for Cost Control.

Dr. Goldhaber has written and edited 10 books and is a frequent international lecturer on the topic of communication. He writes numerous articles on a variety of issues for publication in journals and newspapers across the country, and has served as a political analyst for numerous radio and television shows. He has been selected as a member of Who's Who in America and Who's Who in the World.

See Dr. Gerald Goldhaber's Profile on

©Copyright - All Rights Reserved


Related articles


3/2/2020· Healthcare

Coronavirus (COVID-19)Who's in Charge and What are They Doing About It?

By: Mary Wickens

This brief describes: Which government agencies and health care providers have power to act and what are those powers? Who controls testing and reporting results and who has the power to isolate individuals, impose quarantines and take other steps to mitigate the outbreak.


11/27/2008· Healthcare

It Started With Joe

By: Carol Bradley

It started with Joe. My elderly neighbor had lost his wife and his only child lived in New Jersey. He was totally deaf. How could I not help? My children were then young, and we adopted Joe. How could I have known he would become my charge for over five years


4/12/2017· Healthcare

Getting the Most from Health Care Fraud Expert Witnesses: Lawyer and Expert Best Practices

By: Mary Wickens

Health care fraud and abuse cases are often won or lost on the effective use of expert witnesses. As health care fraud cases have become more complex and technical, the scope and use of expert testimony has proliferated, and the successful use of experts is one of the lawyer's most important jobs. False Claims Act, Anti-Kickback Statute, and Stark Law cases all demand various types of experts to assist the trier of fact in understanding the nature of the case, the morass of rules at play, the evidence, and a variety of billing, valuation, contractual, technical, and compliance concepts. Increasingly, expert reports and testimony play a pivotal role in motions for summary judgment, as well as at trial. Experts also are used in "conference room litigation," such as mediations or negotiations between defense counsel and enforcement agencies. This article is the result of interviews with health care fraud litigators and expert witnesses in the field who identified their best practices to produce optimum outcomes for their clients.

; broker Movie Ad

Follow us

linkedin logo youtube logo rss feed logo